Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).

Details

Ressource 1Download: 1-s2.0-S1279770723015580-main.pdf (152.85 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_DB9E821B10DC
Type
Article: article from journal or magazin.
Collection
Publications
Title
Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).
Journal
The journal of nutrition, health & aging
Author(s)
Carrié I., van Kan G.A., Gillette-Guyonnet S., Andrieu S., Dartigues J.F., Touchon J., Dantoine T., Rouaud O., Bonnefoy M., Robert P., Cuffi M.N., Bories L., Bordes S., Gasnier Y., Desclaux F., Sudres K., Pesce A., Vellas B.
ISSN
1760-4788 (Electronic)
ISSN-L
1279-7707
Publication state
Published
Issued date
04/2012
Peer-reviewed
Oui
Volume
16
Number
4
Pages
355-359
Language
english
Notes
Publication types: Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
1680 participants were randomized over the recruitment period in MAPT study. A total of 1290 participants were recruited in the 7 University Hospital centers, and 390 participants in the 6 memory clinics around Toulouse Gerontopole / Alzheimer Disease research clinical center. The first randomization was on May 30, 2008, and the targeted number of randomized participants was reached on February 24, 2011; 2595 subjects were finally screened, of which 1680 fulfilled the eligibility criteria which represents 64.8%. Approximately, one quarter of screened people refused to participate after the detailed presentation of the study and 4.3% were still interested in participating but missed for unknown reasons the baseline visit even after repeated contacts. Of the 1810 subjects who signed the consent for participating to the study at the baseline visit, 130 (7.1%) were excluded because one of the eligibility criteria was not satisfied. Interestingly, the higher percentage of randomizations compared to screened participants is the personal contact source; almost 85 % of screened participants entered in the study. In an equivalent way, Medias and conferences are efficient recruiting sources to enrol volunteers in the study. Unexpectedly, only about 60% of screened participants from the hospital and GP sources were randomized and 33.2% from health care services. Almost a quarter of the randomized participants come from the hospital outpatients clinics and approximately 20% from public conferences. A total of 1128 contacts yielded to 556 screened volunteers and 345 randomized participants in the coordinating center of Toulouse. Thus, 30 % of contacts were recruited.
Keywords
Aged, Alzheimer Disease/diagnosis, Alzheimer Disease/drug therapy, Alzheimer Disease/prevention & control, Double-Blind Method, Fatty Acids, Omega-3/therapeutic use, Focus Groups, Humans, Patient Compliance, Patient Selection, Randomized Controlled Trials as Topic, Research Design
Pubmed
Web of science
Open Access
Yes
Create date
23/08/2024 7:08
Last modification date
23/08/2024 9:34
Usage data